In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen. - Wikidata - wikimedia - TriplyDB

In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen.

In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen.

http://www.wikidata.org/entity/Q37160845

about

Antimicrobial Effect of Copper Oxide Nanoparticles on Some Oral Bacteria and Candida Species.

P2860

Q51806793-280C7C6E-EC49-4D8E-A46B-0C7759CA0A8A

P2860

In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen.

http://www.wikidata.org/entity/Q37160845

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

In Vitro Activities of Six Ant ...... solates: An Emerging Pathogen.

@en

In Vitro Activities of Six Ant ...... solates: An Emerging Pathogen.

@nl

type

label

In Vitro Activities of Six Ant ...... solates: An Emerging Pathogen.

@en

In Vitro Activities of Six Ant ...... solates: An Emerging Pathogen.

@nl

prefLabel

In Vitro Activities of Six Ant ...... solates: An Emerging Pathogen.

@en

In Vitro Activities of Six Ant ...... solates: An Emerging Pathogen.

@nl

P1433

Q37160845-947CBB92-959E-49D6-8F45-0B0C6B63AB65

P1476

Q37160845-C4A1A501-9D20-4DF0-8737-1227A01ED5AF

P2093

Q37160845-288E909F-2192-4494-8CED-7D0B8786DFB9

Q37160845-B6FEEE9B-74F3-403E-8716-11813E4BF09B

P2860

Q37160845-0348E1AC-03C0-4989-AC1E-00ABC9E79D9B

Q37160845-0CF63C9A-00F2-472D-83B7-F28E2B5919CA

Q37160845-1B486995-1BBE-451B-8CA1-DBD42B865933

Q37160845-1D6CC8E3-7B2F-4777-AB92-32D23E0B765F

Q37160845-27CC597F-C528-4CE1-BCE6-15229F677D7E

Q37160845-29FEE87D-3134-4EDB-86BC-38CD43493AE9

Q37160845-2F8FD59A-61C3-4192-AC51-E54770213B5A

Q37160845-38FF867A-9E58-4C0E-A816-CE519D73513E

Q37160845-3D09DEE8-EA3B-4AFC-883E-4E15048AE951

Q37160845-46A2846A-73C6-4289-8FF9-F2E053C447C7

P304

Q37160845-DDFBFF16-B337-4646-BFB4-CBA0DF4B7F3C

P31

Q37160845-E3E4CC23-7D20-457E-8E0E-5FC20E953D09

P356

Q37160845-9A94D2D8-09F1-4334-9B87-0ACE32B28802

P433

Q37160845-B0564857-1C20-4872-A111-990C07B05F45

P478

Q37160845-64DFE816-5856-4E27-A0C6-9D7168259E56

P50

Q37160845-06117101-F875-4752-9F0A-7D08D6EB6834

Q37160845-1DE8927A-E7F8-4312-9DB1-F0D5105B0A98

Q37160845-2D3477AA-C330-4917-B8F8-C0DB10FFCD2E

Q37160845-518A795F-2AA6-410F-8888-B048DA794639

Q37160845-CED263DC-3931-40AE-87AE-1CE2BD6E9D5D

P577

Q37160845-C7B54E22-0B2E-4535-AE6C-9AFB6699FE4F

P698

Q37160845-FB939F94-7B28-4B19-A869-B51BAF573225

P921

Q37160845-CFE10934-0680-4ECD-A2B0-A78FA0FC8117

P932

Q37160845-9F4C1B04-100A-44F9-A52B-9EFA455E74A2

P356

P1433

Jundishapur journal of microbiology JJM

P1476

In Vitro Activities of Six Ant ...... solates: An Emerging Pathogen.

@en

P2093

Nasrin Amirrajab

http://www.w3.org/2001/XMLSchema#string

Nazanin Lotfi

http://www.w3.org/2001/XMLSchema#string

P2860

Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans

Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome

Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.

Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.

Multilocus sequence typing of Candida albicans isolates from a burn intensive care unit in Iran.

P304

e36638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5812/JJM.36638

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Rasoul Mohammadi

Mojtaba Didehdar

Tahereh Shokohi

Mohammad Hossein Afsarian

P577

2016-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27540459

http://www.w3.org/2001/XMLSchema#string

P921

Candida glabrata

P932

4977912

http://www.w3.org/2001/XMLSchema#string